Abstract: The present invention relates to methods of assessing whether a subject has or is likely to develop a neurodegenerative disease comprising determining whether the subject has a mutation in the C9orf72 gene wherein said mutation prevents or disrupts C9orf72 expression relative to expression in a reference from subjects without the mutation.
Type:
Application
Filed:
August 31, 2012
Publication date:
September 10, 2015
Applicants:
THE UNIVERSITY OF MANCHESTER, NATIONAL INSTITUTE ON AGING, HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA, VU UNIVERSITY MEDICAL CENTRE AMSTERDAM, UCL BUSINESS PLC, UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED
Inventors:
Stuart Pickering-Brown, Bryan Traynor, Andrew B. Singleton, Huw Morris, Peter Heutink, John Hardy, Pentti Tienari